Zydus Lifesciences has received the Establishment Inspection Report (EIR) from the USFDA for its injectable facility located at Zydus Biotech Park, Ahmedabad, with Voluntary Action Indicated (VAI) classification. The GMP surveillance inspection was conducted from April 27 to May 05, 2026.
Zydus Lifesciences (formerly known as Cadila Healthcare), a company limited by shares, incorporated and domiciled in India, operates as an integrated pharmaceutical company with business encompassing the entire value chain in the research, development, production, marketing and distribution of pharmaceutical products.
